My research interests lie at the interface of pharmaceutical sciences, nanotechnology, and cancer biology, with a strong focus on prostate cancer. I am particularly interested in developing advanced drug delivery systems, including lipid-based nanocarriers and nanostructured lipid carriers, for targeted and effective therapies. I am keen on integrating artificial intelligence and experimental design for formulation optimization and predictive modeling. My long-term goal is to contribute to translational strategies that improve therapeutic efficacy and patient outcomes in oncology.